Monica Beneyto
Overview
Explore the profile of Monica Beneyto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
1076
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Piper M, Beneyto M, Burne T, Eyles D, Lewis D, McGrath J
Psychiatr Clin North Am
. 2012 Aug;
35(3):571-84.
PMID: 22929867
The neurodevelopmental hypothesis of schizophrenia suggests that the disruption of early brain development increases the risk of later developing schizophrenia. This hypothesis focuses attention on critical periods of early brain...
2.
Beneyto M, Morris H, Rovensky K, Lewis D
Neuropharmacology
. 2011 Jan;
62(3):1598-605.
PMID: 21215273
Disturbed cortical γ-aminobutyric acid (GABA) neurotransmission in schizophrenia is evident from lamina- and cell type- specific alterations in presynaptic markers. In the dorsolateral prefrontal cortex (DLPFC), these alterations include lower...
3.
Beneyto M, Abbott A, Hashimoto T, Lewis D
Cereb Cortex
. 2010 Sep;
21(5):999-1011.
PMID: 20843900
Dysfunction of the dorsolateral prefrontal cortex (DLPFC) in schizophrenia is associated with lamina-specific alterations in particular subpopulations of interneurons. In pyramidal cells, postsynaptic γ-aminobutyric acid (GABA(A)) receptors containing different α...
4.
Beneyto M, Lewis D
Int J Dev Neurosci
. 2010 Aug;
29(3):295-304.
PMID: 20797429
The hypothesis that schizophrenia results from a developmental, as opposed to a degenerative, process affecting the connectivity and network plasticity of the cerebral cortex is supported by findings from morphological...
5.
Hashimoto T, Nguyen Q, Rotaru D, Keenan T, Arion D, Beneyto M, et al.
Biol Psychiatry
. 2009 Mar;
65(12):1015-23.
PMID: 19249749
Background: In schizophrenia, working memory dysfunction is associated with altered expression of gamma-aminobutyric acid (GABA)(A) receptor alpha1 and alpha2 subunits in the dorsolateral prefrontal cortex (DLPFC). In rodents, cortical alpha...
6.
Beneyto M, Meador-Woodruff J
Neuropsychopharmacology
. 2007 Nov;
33(9):2175-86.
PMID: 18033238
The hypothesis of N-methyl-D-aspartate (NMDA) receptor hypofunction in schizophrenia was initially based on observations that blockade of the NMDA subtype of glutamate receptor by noncompetitive antagonists, such as phencyclidine and...
7.
Beneyto M, Kristiansen L, Oni-Orisan A, McCullumsmith R, Meador-Woodruff J
Neuropsychopharmacology
. 2007 Feb;
32(9):1888-902.
PMID: 17299517
Pharmacological and anatomical evidence suggests that abnormal glutamate neurotransmission may be associated with the pathophysiology of schizophrenia and mood disorders. Medial temporal lobe structural alterations have been implicated in schizophrenia...
8.
McCullumsmith R, Gupta D, Beneyto M, Kreger E, Haroutunian V, Davis K, et al.
Schizophr Res
. 2007 Jan;
90(1-3):15-27.
PMID: 17223013
Several recent studies have found changes in the expression of genes functionally related to myelination and oligodendrocyte homeostasis in schizophrenia. These studies utilized microarrays and quantitative PCR (QPCR), methodologies which...
9.
McCullumsmith R, Kristiansen L, Beneyto M, Scarr E, Dean B, Meador-Woodruff J
Brain Res
. 2006 Nov;
1127(1):108-18.
PMID: 17113057
Objectives: Schizophrenia is associated with dysfunction of glutamatergic neurotransmission, and several studies have suggested glutamatergic abnormalities in bipolar disorder. Recent data suggest involvement of the NMDA receptor signaling complex, which...
10.
Kristiansen L, Huerta I, Beneyto M, Meador-Woodruff J
Curr Opin Pharmacol
. 2006 Nov;
7(1):48-55.
PMID: 17097347
The pathophysiology of schizophrenia is poorly understood but is likely to involve alterations in excitatory glutamatergic signaling molecules in several areas of the brain. Clinical and experimental evidence has shown...